Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib for NF1-related plexiform neurofibroma
2018-001846-32Phase 2Completed
- Sponsor
- Skåne University Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trametinib in plexiform neurofibroma (PN), sponsored by Skåne University Hospital. Primary endpoint: Volumetric partial remission of plexiform neurofibroma. Started Jul 2018; status: completed.
02
Drugs
trametinib
03
Conditions
plexiform neurofibroma (PN)
Beyond the preview
Go deeper on 2018-001846-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001846-32.